Genetics in
the New Millennium - Stem Cells
By Ronald Bachman, MD Chief, Department
of Genetics

Those of us in Genetics believe that research
into the basic science of stem cells will lead to treatment
for genetic disorders, including not only rare conditions
but also common conditions not often thought of as genetic.
These will include neurologic disorders (Parkinson's disease,
Alzheimer's disease, etc.), diabetes, heart disease from
atherosclerosis, and diabetes. In addition to these genetic
conditions, stem cells will be used to treat spinal cord
injuries and leukemia.
There are many sources of human stem cells.
Most feel that embryonic stem cells have the best chance
of success, but the concern is that they must be obtained
from a human embryo. Other sources of stem cells are from
umbilical cord (and placenta) blood collected at birth and
adult stem cells. Adult stem cells can be harvested from
blood or bone marrow. In actuality stem cells have been
found in every organ (e.g. liver, brain, and even skin),
but their numbers are small and they are difficult to collect.
Another source of stem cells are called
cloned stem cells. This was the technology of "Dolly"
and is referred to as "somatic cell nuclear transfer
or SCNT" or cell cloning.

This technology includes removing the
genetic material (DNA) from the nucleus (the center) of
a cell and then introducing the genetic material from another
individual. A stimulus such as an electrical current of
a chemical then is used to induce the egg cell to begin
to divide. This reengineered cell grows into a group of
cells that have the potential to become any tissue of the
body with the appropriate growth conditions. An example
would be inducing these cells to become insulin producing
cells (the beta cells of the pancreas) to treat diabetes.
The concern about the SCNT technology
is that if the group of cells is implanted into a woman's
uterus, it could develop into a baby. This is known as "reproductive
cloning". In genetics we are interested in "theraputic
cloning" which is producing stem cells for the treatment
of disease and not for a new way of producing babies. It
is also known from experimentation using this technology
to produce animals like Dolly, that all were born with some
type of birth defect, immune problem, or a neurologic deficit.
It is for this reason that theraputic cloning and not reproductive
cloning is our goal.
On August 9, 2001 President Bush limited
Federal funding for embryonic and cloned stem cells to a
small number of established embryonic stem cell lines. Private
funding still could be utilized for research on embryonic
and cloned stem cells. Federal funding has been available
for research on umbilical cord and adult stem cells, but
has been limited to about $25 million per year. Because
of this most of the basic embryonic stem cell research is
taking place in other countries (Great Britain, Israel,
South Korea).
On November 2, 2004 the California electorate
approved Proposition 71 with an astounding 59% of the voters.
This proposition was the California Stem Cell Research and
Cures Initiative, which provides $300 M per year (for ten
years) for stem cell research and the development of medical
therapies. It is hoped that this will eventually decrease
health care costs, create more jobs, and stimulate the growth
of the states biotechnology sector. The concerns of opponents
of Proposition 71 are the ethical issue of the use and eventual
loss of embryos, the uncertainty of how useful stem cells
will be, and the increase of the California debt burden
since it will be funded by tax free state bonds. On September
23, 2004 in a New York Time's editorial stated, "in
effect, the proposal would have California pick up the leadership
role that President Bush abdicated".
We are all excited about the possibilities
that stem cells will be the break through for previously
non-treatable genetic disorders. Let me conclude with a
quote, "How'd you like to have your own personal biological
tool repair kit, staying behind, waiting for you at the
local hospital" (Ron Reagan, Jr. at the 2004 Democratic
National Convention).